Cross-talk between the complement system and endothelial cells in physiologic conditions and in vascular diseases, Autoimmunity, vol.39, pp.417-445, 2006. ,
Complement. First of two parts, N Engl J Med, vol.344, pp.1058-66, 2001. ,
Complement: a key system for immune surveillance and homeostasis, Nat Immunol, vol.11, pp.785-97, 2010. ,
Complement interactions with blood cells, endothelial cells and microvesicles in thrombotic and inflammatory conditions, Adv Exp Med Biol, vol.865, pp.19-42, 2015. ,
Dangerous liaisons: complement, coagulation, and kallikrein/kinin cross-talk act as a linchpin in the events leading to thromboinflammation, Immunol Rev, vol.274, pp.245-69, 2016. ,
Contact system: a vascular biology modulator with anticoagulant, profibrinolytic, antiadhesive, and proinflammatory attributes, Blood, vol.90, pp.3819-3862, 1997. ,
Neutrophil-derived proteinase 3 induces kallikrein-independent release of a novel vasoactive kinin, J Immunol, vol.182, pp.7906-7921, 2009. ,
International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences, Pharmacol Rev, vol.57, pp.27-77, 2005. ,
Cross-talk between the complement and the kinin system in vascular permeability, Immunol Lett, vol.140, pp.7-13, 2011. ,
C1-inhibitor decreases the release of vasculitislike chemotactic endothelial microvesicles, J Am Soc Nephrol, vol.28, pp.2472-81, 2017. ,
Contact-system activation in children with vasculitis, Lancet, vol.360, pp.535-576, 2002. ,
Complement system activation in ANCA vasculitis: a translational success story?, Mol Immunol, vol.68, pp.53-59, 2015. ,
Complement in ANCA-associated vasculitis: mechanisms and implications for management, Nat Rev Nephrol, vol.13, pp.359-67, 2017. ,
Advances in childhood vasculitis, Curr Opin Rheumatol, vol.21, pp.411-419, 2009. ,
Classification, epidemiology and clinical subgrouping of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis, Nephrol Dial Transplant, vol.30, pp.14-22, 2015. ,
IgG subclasses of antineutrophil cytoplasm autoantibodies (ANCA), Nephrol Dial Transplant, vol.8, pp.696-702, 1993. ,
The role of complement in antineutrophil cytoplasmic antibody-associated vasculitis, Curr Opin Rheumatol, vol.31, pp.3-8, 2019. ,
Microvesicle transfer of kinin B1-receptors is a novel inflammatory mechanism in vasculitis, Kidney Int, vol.91, pp.96-105, 2017. ,
The many faces of endothelial microparticles, Arterioscler Thromb Vasc Biol, vol.31, pp.27-33, 2011. ,
Endothelial and platelet microparticles in vasculitis of the young, Arthritis Rheum, vol.50, pp.927-963, 2004. ,
Endothelial microparticles and the diagnosis of the vasculitides, Intern Med, vol.43, pp.1115-1124, 2004. ,
Endothelial microparticles as a diagnostic aid in Churg-Strauss vasculitis-induced cardiomyopathy, Clin Exp Rheumatol, vol.26, pp.86-95, 2008. ,
Endothelial injury and repair in systemic vasculitis of the young, Arthritis Rheum, vol.62, pp.1770-80, 2010. ,
Blockade of the kinin B1 receptor ameloriates glomerulonephritis, J Am Soc Nephrol, vol.21, pp.1157-64, 2010. ,
URL : https://hal.archives-ouvertes.fr/inserm-00506236
2012 revised international Chapel Hill consensus conference nomenclature of vasculitides, Arthritis Rheum, vol.65, pp.1-11, 2013. ,
Heteromerization between the Bradykinin B2 receptor and the angiotensin-(1-7) mas receptor: functional consequences, Hypertension, vol.68, pp.1039-1087, 2016. ,
Complement activation associated with ADAMTS13 deficiency in human and murine thrombotic microangiopathy, J Immunol, vol.191, pp.2184-93, 2013. ,
Neurohumoral regulation of precapillary vessels: the kallikrein-kinin system, J Cardiovasc Pharmacol, vol.6, pp.401-413, 1984. ,
The complement and contact activation systems: partnership in pathogenesis beyond angioedema, Immunol Rev, vol.274, pp.281-290, 2016. ,
Coagulation factor XII in thrombosis and inflammation, Blood, vol.131, pp.1903-1912, 2018. ,
Tracking down contact activation -from coagulation in vitro to inflammation in vivo, Int J Lab Hematol, vol.36, pp.374-81, 2014. ,
Complement activation is involved in renal damage in human antineutrophil cytoplasmic autoantibody associated pauci-immune vasculitis, J Clin Immunol, vol.29, pp.282-91, 2009. ,
Identification of the zincdependent endothelial cell binding protein for high molecular weight kininogen and factor XII: identity with the receptor that binds to the globular "heads" of C1q (gC1q-R), Proc Natl Acad Sci U S A, vol.93, pp.8552-8559, 1996. ,
Kallikrein cleaves C3 and activates complement, J Innate Immun, vol.10, pp.94-105, 2018. ,
Inactivation of C3a and C5a octapeptides by carboxypeptidase R and carboxypeptidase N, Microbiol Immunol, vol.46, pp.131-135, 2002. ,
Inactivation of bradykinin by angiotensin-converting enzyme and by carboxypeptidase N in human plasma, Am J Physiol Heart Circ Physiol, vol.278, pp.1069-74, 2000. ,
Current status of tissue kallikrein inhibitors: importance in cancer, Curr Opin Investig Drugs, vol.8, pp.462-470, 2007. ,
Control of the classical and the MBL pathway of complement activation, Mol Immunol, vol.37, pp.803-814, 2000. ,
Pathogenesis and treatment of ANCA-associated vasculitis-a role for complement, Pediatr Nephrol, vol.33, pp.1-11, 2018. ,
Alternative complement pathway in the pathogenesis of disease mediated by anti-neutrophil cytoplasmic autoantibodies, Am J Pathol, vol.170, pp.52-64, 2007. ,
Alternative complement pathway activation products in urine and kidneys of patients with ANCA-associated GN, Clin J Am Soc Nephrol, vol.8, pp.1884-91, 2013. ,
The interaction between circulating complement proteins and cutaneous microvascular endothelial cells in the development of childhood Henoch-Schonlein Purpura, PLoS One, vol.10, p.120411, 2015. ,
The complement system in systemic autoimmune disease, J Autoimmun, vol.34, pp.276-86, 2010. ,
C5a receptor mediates neutrophil activation and ANCA-induced glomerulonephritis, J Am Soc Nephrol, vol.20, pp.289-98, 2009. ,
Increase of circulating neutrophil and platelet microparticles during acute vasculitis and hemodialysis, Kidney Int, vol.69, pp.1416-1439, 2006. ,
Therapeutic targeting of classical and lectin pathways of complement protects from ischemia-reperfusion-induced renal damage, Am J Pathol, vol.176, pp.1648-59, 2010. ,
Plasma-derived C1 esterase inhibitor for acute antibody-mediated rejection following kidney transplantation: results of a randomized double-blind placebo-controlled pilot study, Am J Transplant, vol.16, pp.3468-78, 2016. ,
Membrane cofactor protein of complement is present on human fibroblast, epithelial, and endothelial cells, J Clin Invest, vol.84, pp.538-583, 1989. ,
Decay-accelerating factor is present on cultured human umbilical vein endothelial cells, J Exp Med, vol.163, pp.221-227, 1986. ,
Regulatory control of the terminal complement proteins at the surface of human endothelial cells: neutralization of a C5b-9 inhibitor by antibody to CD59, Blood, vol.76, pp.2572-2579, 1990. ,
Randomized trial of C5a receptor inhibitor avacopan in ANCA-associated Vasculitis, J Am Soc Nephrol, vol.28, pp.2756-67, 2017. ,
Vasculitis: A CLEAR argument for targeting complement in ANCA vasculitis, Nat Rev Nephrol, vol.13, pp.448-50, 2017. ,